These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 20008990
1. PET-derived biodistribution and dosimetry of the benzodiazepine receptor-binding radioligand (11)C-(R)-PK11195 in children and adults. Kumar A, Muzik O, Chugani D, Chakraborty P, Chugani HT. J Nucl Med; 2010 Jan; 51(1):139-44. PubMed ID: 20008990 [Abstract] [Full Text] [Related]
2. Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation. Hirvonen J, Roivainen A, Virta J, Helin S, Någren K, Rinne JO. Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):606-12. PubMed ID: 19862517 [Abstract] [Full Text] [Related]
3. Biodistribution and Radiation Dosimetry of 11C-Nicotine from Whole-Body PET Imaging in Humans. Garg PK, Lokitz SJ, Nazih R, Garg S. J Nucl Med; 2017 Mar; 58(3):473-478. PubMed ID: 27660145 [Abstract] [Full Text] [Related]
4. Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolase. Boileau I, Bloomfield PM, Rusjan P, Mizrahi R, Mufti A, Vitcu I, Kish SJ, Houle S, Wilson AA, Tong J. J Nucl Med; 2014 Dec; 55(12):1993-7. PubMed ID: 25413137 [Abstract] [Full Text] [Related]
5. 1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation. Virta JR, Tolvanen T, Någren K, Brück A, Roivainen A, Rinne JO. J Nucl Med; 2008 Mar; 49(3):347-53. PubMed ID: 18287260 [Abstract] [Full Text] [Related]
6. PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans. Liu N, Li M, Li X, Meng X, Yang G, Zhao S, Yang Y, Ma L, Fu Z, Yu J. J Nucl Med; 2009 Feb; 50(2):303-8. PubMed ID: 19164239 [Abstract] [Full Text] [Related]
7. PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer. Zanzonico PB, Finn R, Pentlow KS, Erdi Y, Beattie B, Akhurst T, Squire O, Morris M, Scher H, McCarthy T, Welch M, Larson SM, Humm JL. J Nucl Med; 2004 Nov; 45(11):1966-71. PubMed ID: 15534070 [Abstract] [Full Text] [Related]
8. Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjects. Van Laere K, Koole M, Sanabria Bohorquez SM, Goffin K, Guenther I, Belanger MJ, Cote J, Rothenberg P, De Lepeleire I, Grachev ID, Hargreaves RJ, Bormans G, Burns HD. J Nucl Med; 2008 Mar; 49(3):439-45. PubMed ID: 18287275 [Abstract] [Full Text] [Related]
9. Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans. Scheinin NM, Tolvanen TK, Wilson IA, Arponen EM, Någren KA, Rinne JO. J Nucl Med; 2007 Jan; 48(1):128-33. PubMed ID: 17204709 [Abstract] [Full Text] [Related]
10. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study. Bretin F, Bahri MA, Bernard C, Warnock G, Aerts J, Mestdagh N, Buchanan T, Otoul C, Koestler F, Mievis F, Giacomelli F, Degueldre C, Hustinx R, Luxen A, Seret A, Plenevaux A, Salmon E. Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813 [Abstract] [Full Text] [Related]
11. PET-Based Human Dosimetry of the Dimeric αvβ3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis. López-Rodríguez V, Galindo-Sarco C, García-Pérez FO, Ferro-Flores G, Arrieta O, Ávila-Rodríguez MA. J Nucl Med; 2016 Mar; 57(3):404-9. PubMed ID: 26585063 [Abstract] [Full Text] [Related]
12. Human biodistribution and radiation dosimetry of the tachykinin NK1 antagonist radioligand [18F]SPA-RQ: comparison of thin-slice, bisected, and 2-dimensional planar image analysis. Sprague DR, Chin FT, Liow JS, Fujita M, Burns HD, Hargreaves R, Stubbs JB, Pike VW, Innis RB, Mozley PD. J Nucl Med; 2007 Jan; 48(1):100-7. PubMed ID: 17204705 [Abstract] [Full Text] [Related]
13. Whole-body biodistribution kinetics, metabolism, and radiation dosimetry estimates of 18F-PEG6-IPQA in nonhuman primates. Tian M, Ogawa K, Wendt R, Mukhopadhyay U, Balatoni J, Fukumitsu N, Uthamanthil R, Borne A, Brammer D, Jackson J, Mawlawi O, Yang B, Alauddin MM, Gelovani JG. J Nucl Med; 2011 Jun; 52(6):934-41. PubMed ID: 21571803 [Abstract] [Full Text] [Related]
14. Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest. Maddahi J, Czernin J, Lazewatsky J, Huang SC, Dahlbom M, Schelbert H, Sparks R, Ehlgen A, Crane P, Zhu Q, Devine M, Phelps M. J Nucl Med; 2011 Sep; 52(9):1490-8. PubMed ID: 21849402 [Abstract] [Full Text] [Related]
15. Biodistribution and dosimetry of [123I]iodo-PK 11195: a potential agent for SPET imaging of the peripheral benzodiazepine receptor. Versijpt J, Dumont F, Thierens H, Jansen H, De Vos F, Slegers G, Santens P, Dierckx RA, Korf J. Eur J Nucl Med; 2000 Sep; 27(9):1326-33. PubMed ID: 11007514 [Abstract] [Full Text] [Related]
16. Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation. Brown AK, Fujita M, Fujimura Y, Liow JS, Stabin M, Ryu YH, Imaizumi M, Hong J, Pike VW, Innis RB. J Nucl Med; 2007 Dec; 48(12):2072-9. PubMed ID: 18006619 [Abstract] [Full Text] [Related]
17. Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results. Sattler B, Kranz M, Starke A, Wilke S, Donat CK, Deuther-Conrad W, Patt M, Schildan A, Patt J, Smits R, Hoepping A, Schoenknecht P, Steinbach J, Brust P, Sabri O. J Nucl Med; 2014 Nov; 55(11):1885-92. PubMed ID: 25286922 [Abstract] [Full Text] [Related]
18. 18F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man 18F-FPYBF-2 PET imaging. Nishii R, Higashi T, Kagawa S, Okuyama C, Kishibe Y, Takahashi M, Okina T, Suzuki N, Hasegawa H, Nagahama Y, Ishizu K, Oishi N, Kimura H, Watanabe H, Ono M, Saji H, Yamauchi H. Ann Nucl Med; 2018 May; 32(4):256-263. PubMed ID: 29453681 [Abstract] [Full Text] [Related]
19. Brain and whole-body imaging in nonhuman primates with [11C]MeS-IMPY, a candidate radioligand for beta-amyloid plaques. Seneca N, Cai L, Liow JS, Zoghbi SS, Gladding RL, Hong J, Pike VW, Innis RB. Nucl Med Biol; 2007 Aug; 34(6):681-9. PubMed ID: 17707808 [Abstract] [Full Text] [Related]
20. Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans. Cropley VL, Fujita M, Musachio JL, Hong J, Ghose S, Sangare J, Nathan PJ, Pike VW, Innis RB. J Nucl Med; 2006 Jan; 47(1):100-4. PubMed ID: 16391193 [Abstract] [Full Text] [Related] Page: [Next] [New Search]